Recently, results from Volcano Corporation's (VOLC) PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) study were published in The New England Journal of ...

Volcano Corporation (Nasdaq: VOLC), a provider of intravascular ultrasound (IVUS) and functional measurement (FM) products designed to enhance the diagnosis and treatment of vascular and structural ...

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This ...

SAN DIEGO, CHRON Volcano Corporation today announced its participation in the Paris course for Revascularization (EuroPCR) from May 17 — 20. Volcano's focus will be on highlighting the strength of its ...

Release of these novel precision guidance tools will be demonstrated in live cases, symposia and training programs throughout the week SAN DIEGO, CA -- Volcano Corporation, a leading company focused ...

Volcano Corporation VOLC, a leading developer and manufacturer of precision guided tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced ...

Amsterdam, the Netherlands - Two US companies are sharing the spoils of Amsterdam cardiovascular device company JOMED, declared bankrupt by the Amsterdam district court in early May 2003. Abbott ...

SAN DIEGO, April 25, 2014 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of ...

Co summarized the role of Intravascular Ultrasound in a shifting Drug Eluting Stent market. Use of DES has decreased from 89% of PCIs in the U.S. down to an estimated 70% over the past year, driven by ...

Co announces approval of the s5i Integrated IVUS System by necessary regulatory authorities in Japan, granting entry into the Japanese mkt. Volcano expects to launch the s5i into Japan, which ...

Enrolling 3,349 patients, the IVUS sub-study is part of the Cardiovascular Research Foundation's (CRF) ADAPT-DES study (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents), a prospective ...

Percutaneous coronary intervention (PCI) is increasingly used for revascularization of unprotected left main coronary artery disease. Whether intravascular ultrasonographic (IVUS) guidance during PCI ...